(Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

WHO to Convene Emergency Meeting on Mpox on Nov. 22 GENEVA (Reuters) -The World Health Organization will convene a meeting of ...

The study will evaluate the safety and efficacy of brincidofovir in treating mpox virus in a randomized double-blind placebo-controlled trial. “We applaud Africa CDC and PANTHER for the launch ...

Another case of the new, mutant strain of mpox has been detected in London, the UK Health Security Agency (UKHSA) has ...

A vial of the mpox vaccine is seen during the launch of the vaccination campaign at the General Hospital of Goma, Dr Congo on ...

Cases of mpox in the region of Congo where a new and more infectious variant was first detected appear to be "plateauing," ...

Congo reported fewer than 100 mpox cases last week, down from nearly 400 in July but infections have risen in Burundi and ...

Both mpox and acne may cause pimples. However, mpox can develop into blisters that can spread to other areas. Acne is a skin condition caused by bacteria, clogged pores, hormonal changes ...

An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations said on Wednesday.

The WHO declared mpox a global public health emergency for the second time in two years in August after a new variant of the virus, called clade Ib, spread from the Democratic Republic of Congo to ...